A novel combination treatment approach extended survival in mice with pancreatic cancer, demonstrating a potential second-line therapy for patients.
Sequencing known cardiac arrythmia genes in more than 20,000 people without an indication for genetic testing identified pathogenic variants in nearly one percent of individuals.
A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.
A new Northwestern Medicine study suggests that some patients with the most common type of heart failure may benefit from a novel, minimally invasive cardiac implant device called an atrial shunt.
Neural stem cells engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2 positive breast cancer brain metastases.
Northwestern scientists have developed a new tool to harness immune cells from tumors to fight cancer rapidly and effectively.
A new therapy showed improvements over the standard treatment for relapsed B-cell lymphoma, according to a recent study.
Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension have the highest risk of cardiovascular disease events, according to a recent study.
A Northwestern Medicine study has found that a new combination immune therapy treatment not only extended cancer patients’ lives better than other treatments, it also was less toxic to their overall health than other drugs on the market.
Using MRI, EEG and clinical characteristics, the pre-surgical workup can predict if patients with epilepsy will benefit from a more invasive examination.
Notifications